Tumorigenic potential of cells with activated mTOR signaling are suppressed by NOTCH inhibition, which indicate that the STAT3/p63/NOTCH axis may serve as a target for the treatment of tumor with hyperactive mTOR signaling [55]. Here, TP63 is linked to neoplasm.